| Literature DB >> 34912668 |
Deepak Krishna1, Gaurav Chaturvedi1, Manal M Khan1, Ved Prakash Rao Cheruvu1, Michael Laitonjam1, Reena Minz1.
Abstract
BACKGROUND: Sensory recovery and durability of the flap is the primary goal of heel soft tissue reconstruction. From the different options, the choice of the flap depends on the size of the defect, its location, and the availability of the donor area.Entities:
Keywords: Calcaneal osteomyelitis; Extended reverse sural artery flap; Heel defect; Heel reconstruction; Medial plantar artery flap
Year: 2021 PMID: 34912668 PMCID: PMC8662685 DOI: 10.29252/wjps.10.3.63
Source DB: PubMed Journal: World J Plast Surg ISSN: 2228-7914
Fig. 1Treatment algorithm of heel soft tissue defects
Fig. 2A. Pre- and Post-operative image of posterior heel defect with avulsion component managed with advancement of avulsed heel. B. Posterior heel defect extending up to Achilles tendon region covered with the islanded RSA flap
Fig. 3A. Neuropathic ulcer at right anterior heel (Left side), Black arrow indicate a subcutaneous vascular bundle of a medial plantar artery proximal to the flap (Middle), 2 months follow-up showing well-settled MPA flap and skin graft (Right side). B. Neuropathic ulcer of 4 cm x 4 cm size at the right anterior heel with elevated extended RSA flap (Left side), 3 months follow-up showing the well-settled flap (Right side)
Fig. 4A. Posttraumatic complete heel defect at the lateral border of the left sole of size 8 cm x 4 cm size with surrounding scarring and marking extended RSA flap up to 4 cm proximal to the popliteal crease (Left side), Exteriorization of pedicle and reach of the flap up to the midfoot (Middle), 1-month follow-up showing 16 cm x 8 cm size flap (Right side). B. Post-traumatic defect at the left heel with the exposed calcaneum (Left side), In second after pedicle division de-epithelized part of the pedicle used for filling the bony cavity (Middle), 2 months follow-up showing complete healing (Right side)
Subjective component of AOFAS hindfoot clinical ratings scale (Maximum score 60)
|
| |
|
None | 40 |
|
Mild, occasional | 30 |
|
Moderate, daily | 20 |
|
Severe, almost always present | 0 |
|
| |
|
Activity limitations, support requirement | |
|
No limitations, no support | 10 |
|
No limitation of daily activities, limitation of recreational activities, no support | 7 |
|
Limited daily and recreational activities, cane | 4 |
|
Severe limitation of daily and recreational activities, walker, crutches, wheelchair, brace | 0 |
|
Maximum distance walking, blocks (1block= 150meter) | |
|
Greater than 6 | 5 |
|
4-6 | 4 |
|
1-3 | 2 |
|
Less than 1 | 0 |
|
Walking surfaces | |
|
No difficulty on any surface | 5 |
|
Some difficulty on uneven terrain, stairs, inclines, ladders | 3 |
|
Severe difficulty on uneven terrain, stairs, inclines, ladders | 0 |
Demographic profile
|
|
|
|---|---|
|
| |
| Male | 35 (87.5) |
| Female | 5 (12.5) |
| Male: Female ratio | 7:1 |
|
| |
| Diabetes | 6 |
| Hypertension | 4 |
| Varicosity | 2 |
| Peripheral nerve injury | 8 |
|
| |
| Trauma | 21 (52.5%) |
| Neuropathic | 12 (30%) |
| Burn | |
| Thermal | 3 (7.5%) |
| Contact | 2 (5%) |
| Malignancy | 2 (5%) |
|
| |
| Anterior | 16 (40%) |
| Posterior | 8 (20%) |
| Complete | 16 (40%) |
Outcome analysis of reconstructed heel with different flaps
| Flap type | Cases (n) | Average size in cm | Complication (n) | Mean AOFAS Score and range (Maximum Mean Score 60) | Sensory recovery in number of cases (n) | |||
|---|---|---|---|---|---|---|---|---|
| Immediate (Marginal necrosis) | Delayed (Ulceration) | Deep | Protective | Touch | ||||
| MPA | 8 | 4×4 | 0 | 2 | 40.50 (44-60) | 8 | 2 | 2 |
| Extended RSA | 16 | 9.5×8 | 1 | 4 | 40.12 (34-47) | 16 | 10 | 0 |
| Islanded RSA | 6 | 6×5 | 0 | 0 | 54.66 (44-60) | 6 | 6 | 0 |
| Local | 6 | 7 | 1 | 0 | 51.33 (44-60) | 6 | 6 | 2 |
| Cross leg | 2 | 8×6.5 | 0 | 0 | 44 | 2 | 2 | 0 |
| Free | 2 | 15×14 | 0 | 0 | 42 | 2 | 0 | 0 |
Outcome analysis between Neuropathic and non-neuropathic heel defect groups
| Group | Delayed ulceration (n) | Return of protective sensation (n) | Mean AOFAS Score and range (Maximum Mean Score 60) |
|---|---|---|---|
| Neuropathic (n=12) | 3 (25%) | 4 (33.3%) | 41 ± 10.7 |
| Non-neuropathic (n=28) | 3 (10.7%) | 22 (78.5%) | 47.5± 6.7 |
|
|
|
|
|